TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,136 | -67.7% | 49,179 | -4.0% | 0.00% | -60.0% |
| Q2 2023 | $1,272,081 | +38.1% | 51,211 | -16.4% | 0.01% | +25.0% |
| Q1 2023 | $921,305 | -51.1% | 61,257 | -61.5% | 0.00% | -55.6% |
| Q4 2022 | $1,884,637 | +95.1% | 159,310 | -2.4% | 0.01% | +80.0% |
| Q3 2022 | $966,000 | +79.2% | 163,215 | +28.8% | 0.01% | +66.7% |
| Q2 2022 | $539,000 | +450.0% | 126,706 | +1135.0% | 0.00% | – |
| Q1 2022 | $98,000 | -66.3% | 10,260 | +36.7% | 0.00% | -100.0% |
| Q2 2021 | $291,000 | -49.9% | 7,505 | -37.7% | 0.00% | -66.7% |
| Q1 2021 | $581,000 | +157.1% | 12,050 | +3.9% | 0.00% | +200.0% |
| Q2 2020 | $226,000 | – | 11,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |